A 3-year study of prevention of postmenopausal bone loss: conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone

Modifications of a specific assay for hydroxyproline in urine

1967 • 1,091 citations

Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis

1990 • 966 citations

LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGEN

1976 • 946 citations

Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal females

1980 • 606 citations

Effect of Estrogens and Calcium Carbonate on Bone Loss in Postmenopausal Women

1977 • 577 citations

Prospective trial of oestrogen and calcium in postmenopausal women.

1977 • 379 citations

Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis.

1980 • 156 citations

Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone loss

1994 • 121 citations

Decreased serum levels of insulin‐like growth factors and IGF binding protein 3 in osteoporosis

1993 • 116 citations

Org OD 14 and the endometrium

1991 • 113 citations

Compliance with hormonal replacement therapy

1991 • 107 citations

Effects of ovariectomy and estrogen on the serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3

1994 • 105 citations

Use of Insulin-Like Growth Factor-Binding Protein 3 for the Evaluation of Growth Disorders

1990 • 104 citations

Clinical aspects of insulin-like growth factor binding proteins.

1991 • 101 citations

Age-Related Changes in Serum Insulin-Like Growth Factor-Binding Proteins in Women*

1990 • 95 citations

Effects of two doses of tibolone on trabecular and cortical bone loss in early postmenopausal women: A two-year randomized, placebo-controlled study

1996 • 90 citations

Non-linear increase in vertebral density induced by a synthetic steroid (Org OD 14) in women with established osteoporosis

1991 • 83 citations

Effect of tibolone on postmenopausal bone loss

1994 • 82 citations

Placebo-controlled cross-over study of effects of Org OD 14 in menopausal women.

1982 • 82 citations

Prevention of Postmenopausal Bone Loss Using Tibolone or Conventional Peroral or Transdermal Hormone Replacement Therapy with 17β-Estradiol and Dydrogesterone

1997 • 80 citations

Multicentre study of effects of Org OD 14 on endometrium, vaginal cytology and cervical mucus in post-menopausal and oophorectomized women

1984 • 64 citations

Women with climacteric symptoms: A target group for prevention of rapid bone loss and osteoporosis

1992 • 59 citations

The incidence of vaginal bleeding with tibolone treatment

1994 • 55 citations

Long-term placebo-controlled efficacy and safety study of Org OD 14 in climacteric women

1987 • 54 citations

Pharmacological studies with (7α,17α)-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one (Org OD 14)

1987 • 53 citations

The response in spinal bone mass to Tibolone treatment is related to bone turnover in elderly women

1997 • 52 citations

Comparative effects on bone mineral density of tibolone, transdermal estrogen and oral estrogen/progestogen therapy in postmenopausal women

1996 • 39 citations

IGFs: function and clinical importance 2 The regulation of osteoblast function by hormones and cytokines with special reference to insulin‐like growth factors and their binding proteins

1993 • 38 citations

IGFs: function and clinical importance 4 Growth hormone, insulin‐like growth factor I, and bone: a clinical review

1993 • 32 citations

[Compliance with hormone replacement therapy].

1995 • 31 citations

Circulating levels of insulin-like growth factor binding protein 3 (IGFBP-3) and insulin-like growth factor I (IGF-I) in perimenopausal women

1994 • 20 citations